DexCom (DXCM) stock forecast for 2024. Forecast tables and graphs.







6 Best Growth Stocks To Buy Now According to Metatrader 5

March 15, 2024 6 Best Growth Stocks To Buy Now According to Metatrader 5

One of the reasons investors prefer growth stocks is that they are expected to perform better than other companies in terms of sales…
Navigating GBP Forecast: Mistakes To Avoid In Forex Trading

March 6, 2024 Navigating GBP Forecast: Mistakes To Avoid In Forex Trading

Human error is common in forex trading and often leads to familiar trading issues. These trading mishaps lead to significant novice traders regularly. …
Trading Penny Stocks for Profit: Expert Insights and Practical Advice

February 22, 2024 Trading Penny Stocks for Profit: Expert Insights and Practical Advice

For aspiring traders and seasoned investors alike, the enticing appeal of penny stocks can be likened to voyaging across the vast oceans, discovering…
Vanskelig å Få Refinansiering: Why Was Your Refinancing Loan Denied?

February 15, 2024 Vanskelig å Få Refinansiering: Why Was Your Refinancing Loan Denied?

At historically low interest rates, refinancing can seem tempting; but applications for refinance could be denied for various reasons. Underwriters need assurances that…

DexCom (DXCM) stock forecast for 2024

Updated: March 27, 2024 (06:38)

Sector: Healthcare

The share price of DexCom, Inc. (DXCM) now

What analysts predict: $149.14
52-week High/Low: $142 / $74.75

50/200 Day Moving Average: $125.18 / $114.17

This figure corresponds to the Average Price over the previous 50/200 days. For DexCom stocks, the 50-day moving average is the resistance level today.

For DexCom stocks, the 200-day moving average is the resistance level today.

Are you interested in DexCom, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the DexCom stock price in 2024. How much will one DexCom share be worth in 2024? Is it worth taking profit / loss on DXCM stock now or waiting? What are analysts' forecasts for DexCom stock?

We forecast DexCom stock performance using neural networks based on historical data on DXCM stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account. This corporation stock prediction results are shown below and presented as a graph, table and text information.

DexCom, Inc. stock forecasts are adjusted once a day based on the closing price of the previous trading day.

The minimum target price for DexCom analysts is $149.14. Today 200 Day Moving Average is the support level (114.17 $). 50 Day Moving Average is the resistance level (125.18 $).




Historical and forecast chart of DexCom, Inc. stock

The chart below shows the historical price of DexCom stock and a prediction chart for the next year. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the DXCM stock price can be found in the table below.


Dexcom, Inc. is a medical equipment company. The company is primarily focused on the design, development and commercialization of continuous glucose monitoring (CGM) systems for use by people with diabetes and healthcare professionals. Its products include Dexcom G6 and Dexcom stake. The G6 is a CGM system that can be used as part of an integrated system with other compatible medical devices and electronic interfaces, which can include automated insulin dosing systems, insulin pumps, blood glucose meters, or other electronic devices used to treat diabetes. Its Dexcom Share remote monitoring system, offered for use with its Dexcom system, uses an app on a patient’s iPhone, iPod touch, iPad or Android mobile device to securely and wirelessly transfer glucose information to the cloud and then to apps on mobile devices to up to five designated recipients who can remotely monitor patient glucose information and receive alerts.

DexCom (DXCM) Forecast for 2024

Month Target Pes. Opt. Vol., %
Apr 140.60 132.17 143.86 8.13 %
May 142.74 137.60 146.39 6.01 %
Jun 142.28 138.18 150.93 8.45 %
Jul 144.90 140.96 149.65 5.81 %
Aug 147.45 144.50 153.23 5.70 %
Sep 149.46 142.40 151.85 6.22 %
Oct 149.70 141.19 158.68 11.02 %
Nov 149.22 142.05 155.90 8.88 %
Dec 153.39 149.96 162.23 7.56 %

DexCom information and performance

DexCom Address

6340 SEQUENCE DRIVE, SAN DIEGO, CA, US

Market Capitalization: 53 999 124 000 $

Market capitalization of the DexCom, Inc. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of DXCM shares in the company outstanding by the market price of one share.

EBITDA: 783 700 000 $

EBITDA of DexCom is earnings before interest, income tax and depreciation of assets.

PE Ratio: 107.64

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: 2.605

Price/earnings to growth

DPS: None

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: None

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: 1.3

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: 1.81
Quarterly Revenue Growth YOY: 0.269
Trailing PE: 107.64

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: 80

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: 14.87

Enterprise Value (EV) /Revenue

EV To EBITDA: 58.78

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: 385515000

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A

DexCom price target for 2024 by month


Target values for the price of one DexCom share for Apr 2024.

The weighted average target price per DexCom share in Apr 2024 is: 140.60.
In Apr, the Positive dynamics for DexCom, Inc. shares will prevail with possible monthly volatility of 8.131% volatility is expected.
Pessimistic target level: 132.17
Optimistic target level: 143.86

Target values for the price of one DexCom share for May 2024.

The weighted average target price per DexCom share in May 2024 is: 142.74.
In May, the Positive dynamics for DexCom, Inc. shares will prevail with possible monthly volatility of 6.006% volatility is expected.
Pessimistic target level: 137.60
Optimistic target level: 146.39

Target values for the price of one DexCom share for Jun 2024.

The weighted average target price per DexCom share in Jun 2024 is: 142.28.
In Jun, the Negative dynamics for DexCom, Inc. shares will prevail with possible monthly volatility of 8.447% volatility is expected.
Pessimistic target level: 138.18
Optimistic target level: 150.93

Target values for the price of one DexCom share for Jul 2024.

The weighted average target price per DexCom share in Jul 2024 is: 144.90.
In Jul, the Positive dynamics for DexCom, Inc. shares will prevail with possible monthly volatility of 5.809% volatility is expected.
Pessimistic target level: 140.96
Optimistic target level: 149.65

Target values for the price of one DexCom share for Aug 2024.

The weighted average target price per DexCom share in Aug 2024 is: 147.45.
In Aug, the Positive dynamics for DexCom, Inc. shares will prevail with possible monthly volatility of 5.697% volatility is expected.
Pessimistic target level: 144.50
Optimistic target level: 153.23

Target values for the price of one DexCom share for Sep 2024.

The weighted average target price per DexCom share in Sep 2024 is: 149.46.
In Sep, the Positive dynamics for DexCom, Inc. shares will prevail with possible monthly volatility of 6.221% volatility is expected.
Pessimistic target level: 142.40
Optimistic target level: 151.85

Target values for the price of one DexCom share for Oct 2024.

The weighted average target price per DexCom share in Oct 2024 is: 149.70.
In Oct, the Positive dynamics for DexCom, Inc. shares will prevail with possible monthly volatility of 11.019% volatility is expected.
Pessimistic target level: 141.19
Optimistic target level: 158.68

Target values for the price of one DexCom share for Nov 2024.

The weighted average target price per DexCom share in Nov 2024 is: 149.22.
In Nov, the Negative dynamics for DexCom, Inc. shares will prevail with possible monthly volatility of 8.883% volatility is expected.
Pessimistic target level: 142.05
Optimistic target level: 155.90

Target values for the price of one DexCom share for Dec 2024.

The weighted average target price per DexCom share in Dec 2024 is: 153.39.
In Dec, the Positive dynamics for DexCom, Inc. shares will prevail with possible monthly volatility of 7.564% volatility is expected.
Pessimistic target level: 149.96
Optimistic target level: 162.23



Related stocks from Healthcare sector


Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.